Mackenzie Financial
DNA icon

Mackenzie Financial’s Ginkgo Bioworks DNA Stock Holding History

Mackenzie Financial’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,744
Closed -$251K – 1613
2024
Q2 		$251K Buy
+18,744
New +$559K ﹤0.01% 1250
2022
Q2 		– Sell
-1,359
Closed -$219K – 1482
2022
Q1 		$219K Buy
1,359
+30
+2% +$5.84K ﹤0.01% 1251
2021
Q4 		$442K Buy
+1,329
New +$631K ﹤0.01% 1019

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mackenzie Financial's DNA Position: Q3 2024 in Review

Mackenzie Financial sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 18,744 shares — an estimated $251K sold.

Mackenzie Financial first reported a position in DNA in Q4 2021 and held it in 3 quarters. The position peaked at $442K in Q4 2021. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Mackenzie Financial reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Mackenzie Financial sold 18,744 Ginkgo Bioworks shares in Q3 2024, an estimated $251K.
  • Mackenzie Financial first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 3 quarters.
  • Mackenzie Financial's Ginkgo Bioworks position peaked at $442K in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Mackenzie Financial's 13F filing for Q3 2024, filed 13 Nov 2024.